rivervest.com
Active Portfolio - RiverVest Venture Partners
http://www.rivervest.com/portfolio
Investing in Life Science Innovation. Has funded 34 and exited or taken public 20 innovative life science companies. Focusing primarily on the medical device and biopharmaceutical industries, RiverVest currently has assets under management of more than $290 million. Allakos, Inc., San Carlos, CA. Amplyx Pharmaceuticals, Inc., LaJolla, CA. InterVene, Inc., Mountain View, CA. Lyric Pharmaceuticals, Inc., San Francisco, CA. Neuros Medical, Inc., Willoughby, OH. Otonomy, Inc., San Diego, CA.
spinoffligandrnd.com
The Rationale - SPINOFF LIGAND R&D Newco
http://www.spinoffligandrnd.com/the-rationale.html
SPINOFF LIGAND R&D Newco. SEC regulations limit the word count in the submission of an unsolicited shareholder proxy proposal and its supporting statement to a mere 500 words, which obviously isn't enough to detail the benefits of a public spinoff concept from a company as complex as Ligand. But we've got more to say. Much more. For now, you can find more information about Ligand Pharmaceuticals ($LGND) at their corporate website. As well as their recent Analyst Day Presentation. Create a free website.
pegsummit.com
Antibodies for Cancer Therapy
http://www.pegsummit.com/Cancer-Antibodies
Immunogenicity and Bioassays Stream. Attendee Demographics Event Features. Soldano Ferrone, M.D., Ph.D., Division of Surgical Oncology, Surgery, Massachusetts General Hospital. Mitchell Ho, Ph.D., Chief, Antibody Therapy Section, Laboratory of Molecular Biology, National Cancer Institute, NIH. Horacio G. Nastri, Ph.D., Senior Director, Antibody Biotherapeutics, Incyte Corporation. Day 1 Day 2. MONDAY, MAY 1. Registration and Morning Coffee. T Strategies Targeting Hematologic and Solid Malignancies. Modif...
en.nexigen.de
Our Partners
http://en.nexigen.de/index.php/en/our-partners
Your browser is out-of-date! Update your browser to view this website correctly. Update my browser now. Nexigen’s chemistry and biology. Nexigen in the news. Nexigen has successfully proven functionality of its proprietary technologies in projects with partners from academia and pharmaceutical industry. Johnson and Johnson Pharmaceutical Research and Development.
de.nexigen.de
Our Partners
http://de.nexigen.de/index.php/en/our-partners
Your browser is out-of-date! Update your browser to view this website correctly. Update my browser now. Nexigen’s chemistry and biology. Nexigen in the news. Nexigen has successfully proven functionality of its proprietary technologies in projects with partners from academia and pharmaceutical industry. Johnson and Johnson Pharmaceutical Research and Development.
sdlifesciences.com
Our Clients — Global Life Sciences Practice Group
http://sdlifesciences.com/our-work/our-clients
Global Life Sciences Practice Group. Real Estate Solutions for the Life Sciences Industry. San Diego Biotech Resources. C&W GLSP was there at the beginning, helping San Diego’s original biotech firm, Hybritech, set the foundation for Southern California’s life science industry. We’re proud to have worked with pioneers and innovators stretching back to the first days of local biotech. Check out the inspiring Hybritech story. Or scroll further down to see who else we have helped:. See Full Client List.
de.nexigen.de
Collaborations
http://de.nexigen.de/index.php/en/our-partners/collaborations
Your browser is out-of-date! Update your browser to view this website correctly. Update my browser now. Nexigen’s chemistry and biology. Nexigen in the news. Nexigen has successfully proven functionality of its proprietary technologies in projects with partners from academia and pharmaceutical industry. Johnson and Johnson Pharmaceutical Research and Development.
cllcure.org
CLL Research Foundation | Drugs in Development
http://www.cllcure.org/clldrugs.html
160; . Raising Funds to Accelerate CLL Research. About our Scientific Advisory Board. Scientific Advisory Board Members. Message from our President. How You Can Help. CLL DRUGS in DEVELOPMENT/APPROVED FOR CLINICAL USE. Please note, that for additional related articles on each drug, please click on the related articleslink at the top right of the page after the individual Medline (Entrez) abstract is chosen). Ц induces apoptosis in HL-60 cells in tissue culture. Nitric acid donors (e.g.,PAPA-NO). Present...
piedmontpartnersgroup.com
Portfolio - Piedmont Partners Group
http://www.piedmontpartnersgroup.com/portfolio.html
Bebe stores, Inc. (BEBE). Heidrick and Struggles (HSII). IPath Pure Beta Coffee ETN (CAFE). Ironclad Performance Wear (ICPW). JetBlue Airways Corporation (JBLU). Financials and Investment Partnerships. Bank of America Corporation (BAC). M3 Funds, LLC. Terrapin Partners, LLC. China Fine Arts Partners, LLC. Blaylock Beal Van, LLC. Full Court Press Communications, Inc. Proudly powered by Weebly.
SOCIAL ENGAGEMENT